Pfizer seeks U.S. approval of COVID-19 booster for children aged 5-11 – National |…
Pfizer Inc PFE.N and its partner BioNTech SE BNTX.O said on Tuesday that they had submitted an application to the U.S. health regulator for the authorization of a booster dose of their COVID-19 vaccine for children aged 5 to 11 years.…